HYPOTENSIVE EFFICACY AND SAFETY OF EPLERENONE IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION

被引：0
|
作者：
Lipski, D. [1 ]
Kostka-Jeziorny, K. [1 ]
Uruski, P. [1 ]
Stryczynski, L. [1 ]
Szczepaniak-Chichel, L. [1 ]
Radziemski, A. [1 ]
Tykarski, A. [1 ]
机构：
[1] Poznan Univ Med Sci, Dept Hypertens Angiol & Internal Med 1, Poznan, Poland
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000492080.64238.0c
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.23.09
引用
收藏
页码：E256 / E256
页数：1
相关论文
共 50 条
  • [31] PREVALENCE OF SECONDARY HYPERTENSION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
    Kvapil, Tomas
    Vaclavik, Jan
    Benesova, Klara
    Jarkovsky, Jiri
    Kocianova, Eva
    Kamasova, Monika
    Jelinek, Libor
    Vykoupil, Karel
    JOURNAL OF HYPERTENSION, 2021, 39 : E357 - E357
  • [32] Efficacy And Safety Of Inhaled Nitrite In Patients With Group 3 Pulmonary Arterial Hypertension
    Koch, C. D.
    Pogozelski, A.
    White, P.
    Parsley, E. L.
    Gladwin, M. T.
    Champion, H. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
    Kuwana, Masataka
    Abe, Kohtaro
    Kinoshita, Hideyuki
    Matsubara, Hiromi
    Minatsuki, Shun
    Murohara, Toyoaki
    Sakao, Seiichiro
    Shirai, Yuichiro
    Tahara, Nobuhiro
    Tsujino, Ichizo
    Takahashi, Kenta
    Kanda, Shingo
    Ogo, Takeshi
    PULMONARY CIRCULATION, 2023, 13 (01)
  • [34] SECONDARY CAUSES OF HYPERTENSION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
    Kvapil, Tomas
    Vaclavik, Jan
    Benesova, Klara
    Jarkovsky, Jiri
    Kocianova, Eva
    Kamasova, Monika
    Jelinek, Libor
    JOURNAL OF HYPERTENSION, 2021, 39 : E406 - E406
  • [35] Efficacy and safety of aprocitentan in patients with resistant hypertension and elevated NT-proBNP
    Weber, Michael
    Bakris, George
    Gimona, Alberto
    Narkiewicz, Krzysztof
    Schlaich, Markus
    Sassi-Sayadi, Mouna
    Wang, Jiguang
    Flack, John
    HYPERTENSION, 2024, 81
  • [36] The effect of spironolactone versus eplerenone on blood pressure targets in resistant hypertension patients
    Matova, O.
    Mishchenko, L. A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
    Valerio, Christopher J.
    Kabunga, Peter
    Coghlan, John G.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 541 - 556
  • [38] Effect of Hypotensive Therapy on Metalloproteinase Activity of the Blood in Patients With Arterial Hypertension
    Mazur, N. A.
    Khezheva, F. M.
    KARDIOLOGIYA, 2009, 49 (02) : 27 - 31
  • [39] Efficacy and safety of eplerenone in heart failure management
    Zheng, Jin
    Wang, Shuangao
    Timoteo, Ana Teresa
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 123 : 163 - 164
  • [40] Transitioning pulmonary arterial hypertension patients from bosentan to macitentan: efficacy and safety data
    Santos, Mario
    Goncalves, Fabienne
    Carvalho, Luisa
    Reis, Abilio
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345